Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.847 Q1 | 202 | 249 | 597 | 33893 | 3484 | 562 | 5.59 | 136.12 | |
2 | Current Drug Targets | journal | 1.512 Q1 | 119 | 161 | 224 | 19288 | 997 | 205 | 4.41 | 119.80 | |
3 | Mini-Reviews in Medicinal Chemistry | journal | 0.975 | 107 | 141 | 272 | 11742 | 944 | 257 | 3.60 | 83.28 | |
4 | Scientific World Journal, The | journal | 0.221 Q3 | 127 | 265 | 389 | 9907 | 260 | 387 | 0.55 | 37.38 | |
5 | Current Cancer Drug Targets | journal | 2.656 Q1 | 103 | 44 | 141 | 7238 | 990 | 136 | 6.36 | 164.50 | |
6 | Current Gene Therapy | journal | 1.267 Q2 | 80 | 46 | 138 | 6424 | 615 | 134 | 4.49 | 139.65 | |
7 | Letters in Organic Chemistry | journal | 0.401 Q4 | 33 | 206 | 159 | 6383 | 114 | 159 | 0.72 | 30.99 | |
8 | Current Diabetes Reviews | journal | 0.320 Q4 | 68 | 39 | 34 | 5507 | 30 | 34 | 0.88 | 141.21 | |
9 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.464 Q2 | 108 | 47 | 137 | 4962 | 589 | 131 | 4.18 | 105.57 | |
10 | Letters in Drug Design and Discovery | journal | 0.227 Q4 | 37 | 114 | 99 | 4853 | 71 | 99 | 0.72 | 42.57 | |
11 | Current Protein and Peptide Science | journal | 2.030 Q1 | 96 | 47 | 134 | 4405 | 556 | 123 | 4.01 | 93.72 | |
12 | Current Enzyme Inhibition | journal | 19 | 29 | 0 | 4245 | 0 | 0 | 0.00 | 146.38 | ||
13 | Current Genomics | journal | 0.401 Q4 | 77 | 47 | 167 | 4014 | 107 | 161 | 0.69 | 85.40 | |
14 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.378 Q4 | 39 | 20 | 85 | 3837 | 93 | 79 | 1.31 | 191.85 | |
15 | Current Cancer Therapy Reviews | journal | 17 | 31 | 0 | 3491 | 0 | 0 | 0.00 | 112.61 | ||
16 | Recent Patents on Anti-Cancer Drug Discovery | journal | 52 | 27 | 0 | 3398 | 0 | 0 | 0.00 | 125.85 | ||
17 | Current Organic Synthesis | journal | 1.677 Q1 | 55 | 22 | 23 | 3320 | 69 | 23 | 3.00 | 150.91 | |
18 | Current Pharmaceutical Analysis | journal | 27 | 32 | 0 | 3266 | 0 | 0 | 0.00 | 102.06 | ||
19 | Infectious Disorders - Drug Targets | journal | 0.965 Q3 | 61 | 27 | 95 | 3047 | 276 | 88 | 2.68 | 112.85 | |
20 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.818 Q3 | 45 | 25 | 112 | 3028 | 290 | 104 | 2.58 | 121.12 | |
21 | Current Computer-Aided Drug Design | journal | 32 | 28 | 0 | 2884 | 0 | 0 | 0.00 | 103.00 | ||
22 | Current Nanoscience | journal | 52 | 35 | 0 | 2729 | 0 | 0 | 0.00 | 77.97 | ||
23 | Current Proteomics | journal | 0.129 Q4 | 27 | 17 | 22 | 2051 | 9 | 22 | 0.41 | 120.65 | |
24 | Egyptian Journal of Chemistry | journal | 0.118 | 29 | 60 | 120 | 1338 | 11 | 120 | 0.09 | 22.30 | |
25 | Jordan Journal of Applied Sciences - Natural Sciences | journal | 0.100 Q4 | 5 | 17 | 52 | 186 | 3 | 52 | 0.03 | 10.94 | |
26 | Cancer Molecular Biology | journal | 0.107 Q4 | 4 | 0 | 3 | 0 | 0 | 3 | 0.00 | 0.00 | |
27 | Comparative and Functional Genomics | journal | 0.493 Q3 | 47 | 0 | 195 | 0 | 243 | 185 | 1.47 | 0.00 | |
28 | Journal of the Egyptian National Cancer Institute | journal | 0.106 Q4 | 28 | 46 | 39 | 0 | 2 | 38 | 0.05 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®